Even with all of those positives and a clear indication

New Post Public Reply Private Reply Replies (2) Message Board
EliteYoda Floatable1 #1554

Even with all of those positives and a clear indication that the Pocket Puffer will be a unique quality product setting itself apart from any other vaporizer on the market, the naysayers will continue to just say that all of the devices from RFMK are just rebranded ecigs from China and so they have no competitive advantage in the sea of vaporizers already on the market. Let me just make a few points along these lines. First of all, there is really only ONE company that actually has the patents for all the technology in virtually all of the vaporizers coming out of China, that is Ruyan, a subsidiary of Dragonite (DGTLF). The problem with the argument they are making is that even the PATENT owners cannot seem to turn a profit, and they own the PATENTs!! So, the point is, even if RFMK owned patents, sure it would be a benefit and advantage to protect their technology from competitors however just having a patent is not the end all and does not necessarily mean revenues would flow in, the key is sales and revenues which requires visibility from marketing. So this argument of theirs is moot because the product space is even with all brands on level footing, what seperates the products is quality, uniqueness of design and marketing. Besides, the other main problem with the argument directed at public shareholders is virtually all of the competition out there in the vaporizer market is by private companys basically just acting as distributors. They harp on RFMK saying its nothing special, they are just middle men taking tech from China branding it and selling it, but that is what 99.9% of the companies selling vaporizers are out there doing already. The only one that owns the patents is having its own problems. Besides, no one can invest into any of those private vaporizer companies anyway. Name one other PUBLIC company, you can invest in, besides RFMK, which is selling a revolutionary vaping device for MMJ!! YOU CANT!

The hate for RFMK is obvious and apparent but what is difficult to see is the future. RFMK's future potential is what is unknown and the share price should in theory reflect this potential. Many pink sheets stocks out there only sell a fantasy about an upcoming product, no sales, no product, etc. RFMK has a product, RFMK has sales ongoing, which means revenues will be shown in upcoming quarterly reports. This is more than I can say for other pink sheet stocks, so the question for the bashers is, what would you have us invest in?! Anything?! Or are we to become like them, shaking scared in their fox holes with no skin in the game, too scared to take a chance and put their money where their mouth is apparently because they have been burned too many times by failed investments and scams? I choose to INVEST. I choose to back RFMK because I think management has taken control of the business this year and they are executing on their plans. The potential is great and the current share price does not in any way reflect this potential, in fact, it is not even properly accounting for the value from the inventory (even if not sold yet, once sold, the valuation is higher because of the resultant profits). Its a mystery why RFMK has so many enemies in the form of a myriad screen names we know only bash other stocks as well, there are none that are suggested or discussed fairly and openly, only bashed. Their limited analysis of most pink stocks is jaded from their own poor trading performance and history of dealing with many other pink stocks which there indeed have been many scam pink stocks in the past. RFMK is legit, they brand their own ecig device, and its true they do not have a patent but its not stopping them from selling the CannaCig or the Pocket Puffer like hotcakes and its not stopping investors from taking a look and seeing that the potential to make a very good return on investment in RFMK exists.

GLTA!

$RFMK!

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading